← FDA Drug Approvals (Drugs@FDA)

DESMOPRESSIN ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2023-03-20

Drug application

FDA Application #
ANDA216904
Application type
Abbreviated New Drug Application (Generic)
Brand name
DESMOPRESSIN ACETATE
Generic name
DESMOPRESSIN ACETATE
Active ingredients
DESMOPRESSIN ACETATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Sun Pharmaceutical Industries Limited
First approval
2023-03-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown